Portal Hypertension &Cirrhosis, Volume 5, Issue 3, Page 304-305, September 2026.
wiley +1 more source
Lactulose for Preventing Overt Hepatic Encephalopathy: Between Evidence and Unresolved Questions. [PDF]
Ridola L, Gioia S, Nardelli S.
europepmc +1 more source
Minimal Hepatic Encephalopathy: A Narrative Review. [PDF]
Pitton Rissardo J +13 more
europepmc +1 more source
Sub chronic toxicity studies of lactulose in rats.
Lactulose has profound health benefits by way of increasing bifidobacterial flora in the intestine of infants thereby protecting them against enteric infection, constipation and systemic encephalopathy.
Vishwanatha, S. +4 more
core +1 more source
Clinical guideline: ACG clinical guideline on hepatic encephalopathy. [PDF]
Patel N.
europepmc +1 more source
Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report. [PDF]
Dey R +6 more
europepmc +1 more source
Evaluation of lactulose synthesis using immobilized β-galactosidase in different reactor configurations. [PDF]
de Sousa CC +5 more
europepmc +1 more source
Shelf-life of spray-dried infant formula supplemented with lactulose.
Storage studies were carried out to assess the stability of a lactulose-containing infant food formula (Il) in comparison with a control formula (I) at, 5, 27 and 38C up to 20 weeks. Products were packed in tinned containers and sealed in nitrogen. No
Mahadevamma, L. +3 more
core
Secretagogue laxatives as a potential strategy to overcome adherence barriers to over-the-counter treatment for clozapine-induced constipation. [PDF]
Leung JG, Markota M, Wang XJ.
europepmc +1 more source
Quality of Life in Patients with Hepatic Encephalopathy Treated with Rifaximin: A Systematic Review. [PDF]
Sacco R +3 more
europepmc +1 more source

